Study: Having Medicaid increases emergency room visits
Unique study on Oregon’s citizens sheds light on critical care in the U.S.
New medical operations
At MIT’s ‘Innovations in Health Care’ conference, industry experts discuss how to maintain quality while reining in costs.
Doctor, doctor: Why the job market for married couples in medicine works well
New study in the growing ‘market design’ field of economics explains how a job-market algorithm helps land couples in the same locations.
Military medicine
Senior Laura Lu’s years at MIT have included cancer research, ROTC leadership, and prosthesis trials — and she aims to put her talents to use one day as a Navy surgeon.
MIT team receives $10.4 million biomanufacturing grant from DARPA
With the grant, MIT’s Biomanufacturing Research Program aims to develop new technologies that can rapidly manufacture biologic drugs on the battlefield.
The science of collaboration
The future of biomedical innovation depends in part on learning from the trend for all players to work together for the common goal, say two MIT researchers.
Nanosensors could aid drug manufacturing
Chemical engineers find that arrays of carbon nanotubes can detect flaws in drugs and help improve production.
Why tumors become drug-resistant
New findings could lead to drugs that fight back when tumors don’t respond to treatment.
Seeing the human pulse
An algorithm that can accurately gauge heart rate by measuring tiny head movements in video data could ultimately help diagnose cardiac disease.
Allocating flu vaccines to maximize number of people remaining healthy
Research could help prevent millions of people from becoming infected with the next pandemic flu
Students take their LGO tools to African clinics
Students in Global Health Delivery Lab course help deliver health care to resource-limited areas in sub-Saharan Africa and South Asia
Research advances therapy to protect against dengue virus
MIT team presents a novel approach to developing a treatment using mutated antibodies.
The half-billion-dollar idea
While at MIT, alumnus Todd Zion developed an insulin product that ultimately drew the attention of a pharmaceutical giant.